Kura Oncology Stock Quote KURA - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

17.4899

Bid

17.44

Ask

17.48

Volume

301,213

17.32 Day's Range 17.90

7.41 52 Week Range 24.17

Market Cap

1.33B

Previous Close

17.68

Open

17.61

Last Trade

17.45

Last Trade Time

11:00:31

Financial Volume

$ 5,326,811

VWAP

17.6845

Average Volume (3m)

1,147,984

Shares Outstanding

76,136,963

Dividend Yield

PE Ratio

-8.71

Earnings Per Share (EPS)

-2

Revenue

Net Profit

-152.63M

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progressi... Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. The company has a lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Blank Checks

Website

www.kuraoncology.com

Headquarters

Wilmington, Delaware, USA

Founded

2015

Kura Oncology Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KURA. The last closing price for Kura Oncology was $17.68. Over the last year, Kura Oncology shares have traded in a share price range of $ 7.41 to $ 24.17.

Kura Oncology currently has 76,136,963 shares outstanding. The market capitalization of Kura Oncology is $1.33 billion. Kura Oncology has a price to earnings ratio (PE ratio) of -8.71.

Overall Flow

Bullish

Net Premium

26k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

Kura Oncology Doses First Patient in KOMET-008 Trial of Ziftomenib in Combination with Standards of Care, Including FLT3 Inhibitor, in Acute Myeloid Leukemia

– KOMET-008 is evaluating ziftomenib in combination with gilteritinib, FLAG-IDA or LDAC in patients with relapsed/refractory NPM1-mutant or KMT2A-rearranged AML – SAN DIEGO, Feb. 26, 2024...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-2.8101	-13.8428571429	20.3	20.3	17.3	914730	18.35747861	CS
4	-4.2401	-19.5126553152	21.73	21.96	17.3	754784	19.98652962	CS
12	-1.4501	-7.65628299894	18.94	24.17	17.3	1147984	20.79244514	CS
26	9.1499	109.711031175	8.34	24.17	7.41	1211535	16.61036411	CS
52	6.5399	59.7251141553	10.95	24.17	7.41	982590	14.321383	CS
156	-10.9501	-38.5024613221	28.44	29.21	7.41	833246	15.18554815	CS
260	2.5699	17.2245308311	14.92	42.82	6.34	703737	17.62910502	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EGOXNext e GO NV	$ 0.0599 (66.39%)	251.96M
NVFYNova Lifestyle Inc	$ 3.4199 (62.08%)	20.08M
RWODRedwoods Acquisition Corporation	$ 10.6607 (33.32%)	5.42M
SHOTWSafety Shot Inc	$ 0.3998 (33.27%)	6.3k
TWGTop Wealth Group Holding Ltd	$ 2.28 (23.24%)	5.27M
SBFMSunshine Biopharma Inc	$ 2.1195 (-36.16%)	6.62M
ISPCiSpecimen Inc	$ 0.291 (-30.88%)	1.5M
NCRANocera Inc	$ 1.00 (-21.88%)	3k
BGLCBioNexus Gene Lab Corporation	$ 0.67 (-21.05%)	421.34k
DWSNDawson Geophysical Company	$ 1.74 (-20.55%)	22.65k
EGOXNext e GO NV	$ 0.0599 (66.39%)	251.96M
AGBAAGBA Group Holding Ltd	$ 1.165 (13.11%)	84.35M
SQQQProShares UltraPro Short QQQ	$ 12.385 (2.61%)	76.05M
SINTSiNtx Technologies Inc	$ 0.0465 (16.25%)	59.46M
TQQQProShares UltraPro QQQ	$ 51.50 (-2.37%)	36.08M